In prostate cancer, epsins-1 and -2 are up-regulated and depletion or knockdown inhibits tumorigenesis and progression in both human xenograft and spontaneous developing prostate cancer mouse models [61]. This evidence concerns the gene EPN1 and prostate cancer.